{"transactions":[{"id":1589462,"issuer":{"id":93373,"kind":"organization","name":"Ambrx Biopharma, Inc.","symbol":"AMAM"},"owners":[{"id":93374,"kind":"person","name":"DALESANDRO MARGARET","position":1,"cik":"0001208853","reported_name":"DALESANDRO MARGARET","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2024-03-07T17:36:33.000Z","date":"2024-03-07","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":10119,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"This Form 4 reports securities disposed of pursuant to the terms of the Agreement and Plan of Merger (the \"Merger Agreement\"), dated as of January 5, 2024, among the Issuer, Johnson & Johnson (\"J&J\"), and Charm Merger Sub, Inc., a wholly owned subsidiary of J&J (\"Merger Sub\"), pursuant to which Merger Sub merged with and into the Issuer (the \"Merger\"), effective as of March 7, 2024 (such date and time of such Merger, the \"Effective Time\"), with the Issuer surviving the Merger as a wholly owned subsidiary of J&J."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each of these restricted stock units (\"RSUs\") represents a contingent right to receive one share of common stock of the Issuer (\"Company Common Stock\")."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the Merger Agreement, at the Effective Time, each of these RSUs that was outstanding as of immediately prior to the Effective Time was cancelled and the Reporting Person was entitled to receive the Merger Consideration, without interest and less any applicable withholding taxes, in respect of each such RSU."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The RSUs vest on the earlier of (i) the one-year anniversary of the date of grant of September 1, 2023, and (ii) the day immediately before the next annual general meeting, subject to continuous service through such vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The RSUs vest on the earlier of (i) the one-year anniversary of the date of grant of September 1, 2023, and (ii) the day immediately before the next annual general meeting, subject to continuous service through such vesting date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":10119},"source":{"system":"sec-edgar","filing":"0000950170-24-028177","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1990550/000095017024028177/ownership.xml","form_type":"4"}},{"id":1589461,"issuer":{"id":93373,"kind":"organization","name":"Ambrx Biopharma, Inc.","symbol":"AMAM"},"owners":[{"id":93374,"kind":"person","name":"DALESANDRO MARGARET","position":1,"cik":"0001208853","reported_name":"DALESANDRO MARGARET","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2024-03-07T17:36:33.000Z","date":"2024-03-07","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":17857,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"This Form 4 reports securities disposed of pursuant to the terms of the Agreement and Plan of Merger (the \"Merger Agreement\"), dated as of January 5, 2024, among the Issuer, Johnson & Johnson (\"J&J\"), and Charm Merger Sub, Inc., a wholly owned subsidiary of J&J (\"Merger Sub\"), pursuant to which Merger Sub merged with and into the Issuer (the \"Merger\"), effective as of March 7, 2024 (such date and time of such Merger, the \"Effective Time\"), with the Issuer surviving the Merger as a wholly owned subsidiary of J&J."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each of these restricted stock units (\"RSUs\") represents a contingent right to receive one share of common stock of the Issuer (\"Company Common Stock\")."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the Merger Agreement, at the Effective Time, each of these RSUs that was outstanding as of immediately prior to the Effective Time was cancelled and the Reporting Person was entitled to receive the Merger Consideration, without interest and less any applicable withholding taxes, in respect of each such RSU."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs vest in three successive equal annual installments beginning on September 1, 2024, subject to continuous service through such vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs vest in three successive equal annual installments beginning on September 1, 2024, subject to continuous service through such vesting date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":17857},"source":{"system":"sec-edgar","filing":"0000950170-24-028177","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1990550/000095017024028177/ownership.xml","form_type":"4"}},{"id":1602651,"issuer":{"id":8098,"kind":"organization","name":"Skye Bioscience, Inc.","symbol":"SKYE"},"owners":[{"id":93374,"kind":"person","name":"DALESANDRO MARGARET","position":1,"cik":"0001208853","reported_name":"DALESANDRO MARGARET","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-03-04T06:24:28.000Z","date":"2024-02-29","kind":"grant","planned":false,"acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option grant shall be exercisable for a price of $14.56 per option share for ten years from February 29, 2024 and the options will vest in equal monthly installments over the one year period beginning February 29, 2024."}],"balance_after":35000,"derivative":{"exercise_price":14.56,"expiration_date":"2034-03-01","underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001516551-24-000027","document":"wk-form4_1709551460.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1208853/000151655124000027/wk-form4_1709551460.xml","form_type":"4"}},{"id":1684669,"issuer":{"id":93662,"kind":"organization","name":"SEELOS THERAPEUTICS, INC.","symbol":"SEEL"},"owners":[{"id":93374,"kind":"person","name":"DALESANDRO MARGARET","position":1,"cik":"0001208853","reported_name":"DALESANDRO MARGARET","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-01-08T21:45:51.000Z","date":"2024-01-04","kind":"grant","planned":false,"acquired":true,"shares":1666,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/12th of the shares subject to the option shall vest on February 4, 2024, and 1/12th of the shares subject to the option shall vest monthly thereafter."}],"balance_after":1666,"derivative":{"exercise_price":1.33,"expiration_date":"2034-01-04","underlying":"Common Stock","underlying_shares":1666},"source":{"system":"sec-edgar","filing":"0001104659-24-002385","document":"tm242318-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1017491/000110465924002385/tm242318-3_4seq1.xml","form_type":"4"}},{"id":1748484,"issuer":{"id":8098,"kind":"organization","name":"Skye Bioscience, Inc.","symbol":"SKYE"},"owners":[{"id":93374,"kind":"person","name":"DALESANDRO MARGARET","position":1,"cik":"0001208853","reported_name":"DALESANDRO MARGARET","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-11-06T20:29:36.000Z","date":"2023-11-06","kind":"grant","planned":false,"acquired":true,"shares":14110,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option grant shall be exercisable for a price of $3.50 per option share for ten years from August 25, 2023 and the options will vest in equal monthly installments over the one year period beginning August 24, 2023."}],"balance_after":20001,"derivative":{"exercise_price":3.5,"expiration_date":"2033-08-25","underlying":"Common Stock","underlying_shares":14110},"source":{"system":"sec-edgar","filing":"0001516551-23-000094","document":"wk-form4_1699320568.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1208853/000151655123000094/wk-form4_1699320568.xml","form_type":"4"}},{"id":1787389,"issuer":{"id":109604,"kind":"organization","name":"Ambrx Biopharma Inc.","symbol":"AMAM"},"owners":[{"id":93374,"kind":"person","name":"DALESANDRO MARGARET","position":1,"cik":"0001208853","reported_name":"DALESANDRO MARGARET","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2023-09-06T17:52:23.000Z","date":"2023-09-01","kind":"grant","planned":false,"acquired":true,"shares":70833,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares of the Issuer may be represented by the Issuer's American Depositary Shares (\"ADSs\"). Each ADS represents seven (7) Ordinary Shares of the Issuer."},{"field":"shares","element":"transactionShares","label":"F3","text":"Represents the grant of RSUs payable solely in Ordinary Shares of the Issuer that vest on the earlier of (i) the one-year anniversary of the date of grant, and (ii) the day immediately before the next annual general meeting, subject to continuous service through such vesting date."}],"balance_after":70833,"source":{"system":"sec-edgar","filing":"0000950170-23-046801","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1836056/000095017023046801/ownership.xml","form_type":"4"}},{"id":1787388,"issuer":{"id":109604,"kind":"organization","name":"Ambrx Biopharma Inc.","symbol":"AMAM"},"owners":[{"id":93374,"kind":"person","name":"DALESANDRO MARGARET","position":1,"cik":"0001208853","reported_name":"DALESANDRO MARGARET","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2023-09-06T17:52:23.000Z","date":"2023-09-01","kind":"grant","planned":false,"acquired":true,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares of the Issuer may be represented by the Issuer's American Depositary Shares (\"ADSs\"). Each ADS represents seven (7) Ordinary Shares of the Issuer."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the grant of Restricted Stock Units (the \"RSUs\") payable solely in Ordinary Shares of the Issuer that vest in three successive equal annual installments beginning on September 1, 2024, subject to continuous service through such vesting date."}],"balance_after":125000,"source":{"system":"sec-edgar","filing":"0000950170-23-046801","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1836056/000095017023046801/ownership.xml","form_type":"4"}},{"id":1794062,"issuer":{"id":8098,"kind":"organization","name":"Skye Bioscience, Inc.","symbol":"SKYE"},"owners":[{"id":93374,"kind":"person","name":"DALESANDRO MARGARET","position":1,"cik":"0001208853","reported_name":"DALESANDRO MARGARET","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-08-29T18:21:11.000Z","date":"2023-08-25","kind":"grant","planned":false,"acquired":true,"shares":1472692,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option grant shall be exercisable for a price of $0.014 per option share for ten years from August 25, 2023 and the options will vest in equal monthly installments over the one year period beginning August 24, 2023."}],"balance_after":1472692,"derivative":{"exercise_price":0.014,"expiration_date":"2033-08-25","underlying":"Common Stock","underlying_shares":1472692},"source":{"system":"sec-edgar","filing":"0001516551-23-000058","document":"wk-form4_1693347662.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1208853/000151655123000058/wk-form4_1693347662.xml","form_type":"4"}},{"id":2058643,"issuer":{"id":8098,"kind":"organization","name":"Skye Bioscience, Inc.","symbol":"SKYE"},"owners":[{"id":93374,"kind":"person","name":"DALESANDRO MARGARET","position":1,"cik":"0001208853","reported_name":"DALESANDRO MARGARET","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-01-09T11:23:22.000Z","date":"2023-01-05","kind":"grant","acquired":true,"shares":250000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option grant shall be exercisable for a price of $0.017 per option share for ten years from January 5, 2023 and the options will vest in equal monthly installments over the one year period beginning December 8, 2022."}],"balance_after":250000,"derivative":{"exercise_price":0.017,"expiration_date":"2033-01-05","underlying":"Common Stock","underlying_shares":250000},"source":{"system":"sec-edgar","filing":"0001516551-23-000012","document":"wf-form4_167328138631481.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1208853/000151655123000012/wf-form4_167328138631481.xml","form_type":"4"}},{"id":2063819,"issuer":{"id":93662,"kind":"organization","name":"SEELOS THERAPEUTICS, INC.","symbol":"SEEL"},"owners":[{"id":93374,"kind":"person","name":"DALESANDRO MARGARET","position":1,"cik":"0001208853","reported_name":"DALESANDRO MARGARET","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-01-05T19:19:14.000Z","date":"2023-01-05","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/12th of the shares subject to the option shall vest on February 5, 2023, and 1/12th of the shares subject to the option shall vest monthly thereafter."}],"balance_after":50000,"derivative":{"exercise_price":0.81,"expiration_date":"2033-01-05","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001136261-23-000006","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1017491/000113626123000006/ownership.xml","form_type":"4"}},{"id":2254147,"issuer":{"id":93662,"kind":"organization","name":"SEELOS THERAPEUTICS, INC.","symbol":"SEEL"},"owners":[{"id":93374,"kind":"person","name":"DALESANDRO MARGARET","position":1,"cik":"0001208853","reported_name":"DALESANDRO MARGARET","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-05-27T16:29:17.000Z","date":"2022-05-26","kind":"purchase","acquired":true,"shares":35000,"price":0.599,"value":20965.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average purchase price. These shares were acquired in multiple open market transactions at prices ranging from $0.5939 per share to $0.60 per share, inclusive. The Reporting Person undertakes to provide to the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares acquired at each separate price."}],"balance_after":35000,"source":{"system":"sec-edgar","filing":"0001136261-22-000247","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1017491/000113626122000247/ownership.xml","form_type":"4"}},{"id":2442019,"issuer":{"id":93662,"kind":"organization","name":"SEELOS THERAPEUTICS, INC.","symbol":"SEEL"},"owners":[{"id":93374,"kind":"person","name":"DALESANDRO MARGARET","position":1,"cik":"0001208853","reported_name":"DALESANDRO MARGARET","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-01-06T20:04:26.000Z","date":"2022-01-05","kind":"grant","acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/12th of the shares subject to the option shall vest on February 5, 2022, and 1/12th of the shares subject to the option shall vest monthly thereafter."}],"balance_after":35000,"derivative":{"exercise_price":1.56,"expiration_date":"2032-01-05","underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001136261-22-000019","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1017491/000113626122000019/ownership.xml","form_type":"4"}},{"id":2567484,"issuer":{"id":8098,"kind":"organization","name":"Skye Bioscience, Inc.","symbol":"SKYE"},"owners":[{"id":93374,"kind":"person","name":"DALESANDRO MARGARET","position":1,"cik":"0001208853","reported_name":"DALESANDRO MARGARET","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2021-09-16T16:04:04.000Z","date":"2021-09-14","kind":"grant","acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Option shall be exercisable for a price of $0.12 per Option Share in twelve equal monthly installments such that all the Option Shares shall vest in twelve months."}],"balance_after":400000,"derivative":{"exercise_price":0.12,"expiration_date":"2031-09-14","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001628280-21-018756","document":"wf-form4_163182260221131.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1208853/000162828021018756/wf-form4_163182260221131.xml","form_type":"4"}},{"id":2582364,"issuer":{"id":93662,"kind":"organization","name":"SEELOS THERAPEUTICS, INC.","symbol":"SEEL"},"owners":[{"id":93374,"kind":"person","name":"DALESANDRO MARGARET","position":1,"cik":"0001208853","reported_name":"DALESANDRO MARGARET","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-09-02T16:08:35.000Z","date":"2021-09-01","kind":"grant","acquired":true,"shares":42000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-third of the shares subject to the option shall vest on September 1, 2022, and 1/36th of the shares subject to the option shall vest monthly thereafter, subject to the Reporting Person's continued service to the Issuer through each such vesting date."}],"derivative":{"exercise_price":2.16,"expiration_date":"2031-09-01","underlying":"Common Stock","underlying_shares":42000},"source":{"system":"sec-edgar","filing":"0001136261-21-000208","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1017491/000113626121000208/ownership.xml","form_type":"4"}},{"id":2590794,"issuer":{"id":117092,"kind":"organization","name":"ONCOSEC MEDICAL Inc","symbol":"ONCS"},"owners":[{"id":93374,"kind":"person","name":"DALESANDRO MARGARET","position":1,"cik":"0001208853","reported_name":"DALESANDRO MARGARET","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-08-25T17:31:11.000Z","date":"2021-08-23","kind":"purchase","acquired":true,"shares":20000,"price":1.89,"value":37800.0,"ownership":{"direct":true},"balance_after":20000,"source":{"system":"sec-edgar","filing":"0001493152-21-021268","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1444307/000149315221021268/ownership.xml","form_type":"4"}},{"id":2651633,"issuer":{"id":117092,"kind":"organization","name":"ONCOSEC MEDICAL Inc","symbol":"ONCS"},"owners":[{"id":93374,"kind":"person","name":"DALESANDRO MARGARET","position":1,"cik":"0001208853","reported_name":"DALESANDRO MARGARET","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-29T19:36:23.000Z","date":"2021-06-28","kind":"grant","acquired":true,"shares":37500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest in equal quarterly installments over the next year."}],"balance_after":37500,"derivative":{"exercise_price":3.16,"exercise_date":"2021-06-28","expiration_date":"2031-06-28","underlying":"Common Stock","underlying_shares":37500},"source":{"system":"sec-edgar","filing":"0001493152-21-015612","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1444307/000149315221015612/ownership.xml","form_type":"4"}},{"id":3030049,"issuer":{"id":117092,"kind":"organization","name":"ONCOSEC MEDICAL Inc","symbol":"ONCS"},"owners":[{"id":93374,"kind":"person","name":"DALESANDRO MARGARET","position":1,"cik":"0001208853","reported_name":"DALESANDRO MARGARET","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-09-16T20:00:13.000Z","date":"2020-09-14","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests quarterly over the next year."}],"balance_after":25000,"derivative":{"exercise_price":3.43,"exercise_date":"2020-12-14","expiration_date":"2030-09-14","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001493152-20-017933","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1444307/000149315220017933/ownership.xml","form_type":"4"}},{"id":3059965,"issuer":{"id":8098,"kind":"organization","name":"Skye Bioscience, Inc.","symbol":"SKYE"},"owners":[{"id":93374,"kind":"person","name":"DALESANDRO MARGARET","position":1,"cik":"0001208853","reported_name":"DALESANDRO MARGARET","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Option Grant (Right to Buy)","published_at":"2020-08-12T10:29:54.000Z","date":"2020-08-07","kind":"grant","acquired":true,"shares":250000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each of the Options shall be exercisable for a price of $0.045 per Option Share for ten years from August 7, 2020 (the \"Grant Date\") and all\nOptions will vest 10% on the Grant Date and 90% in equal semiannual installments over two years."}],"balance_after":250000,"derivative":{"exercise_price":0.045,"expiration_date":"2030-08-07","underlying":"Common Stock","underlying_shares":250000},"source":{"system":"sec-edgar","filing":"0001640334-20-002044","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1208853/000164033420002044/primary_doc.xml","form_type":"4"}},{"id":3123857,"issuer":{"id":117092,"kind":"organization","name":"ONCOSEC MEDICAL Inc","symbol":"ONCS"},"owners":[{"id":93374,"kind":"person","name":"DALESANDRO MARGARET","position":1,"cik":"0001208853","reported_name":"DALESANDRO MARGARET","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-06-03T21:12:45.000Z","date":"2020-05-29","kind":"grant","acquired":true,"shares":37500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"The option grant was approved by the Issuer's Compensation Committee on April 14, 2020, subject to stockholder approval of an amendment to the Issuer's 2011 Incentive Plan to increase the number of authorized shares. The Issuer's stockholders approved the plan amendment on May 29, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option was 25% vested on April 14, 2020, and the remainder vests quarterly over the next three years."}],"balance_after":37500,"derivative":{"exercise_price":1.56,"exercise_date":"2020-04-14","expiration_date":"2030-04-14","underlying":"Common Stock","underlying_shares":37500},"source":{"system":"sec-edgar","filing":"0001493152-20-010508","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1444307/000149315220010508/ownership.xml","form_type":"4"}},{"id":3547514,"issuer":{"id":117092,"kind":"organization","name":"ONCOSEC MEDICAL Inc","symbol":"ONCS"},"owners":[{"id":93374,"kind":"person","name":"DALESANDRO MARGARET","position":1,"cik":"0001208853","reported_name":"DALESANDRO MARGARET","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-04-26T18:15:22.000Z","date":"2019-04-24","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Vesting will occur in 12 equal monthly increments, with the first 1/12th vesting on the first month anniversary of the Grant Date pursuant to the OncoSec Medical Incorporated 2011 Stock Incentive Plan."}],"balance_after":100000,"derivative":{"exercise_price":0.58,"exercise_date":"2019-05-24","expiration_date":"2029-04-24","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001493152-19-006033","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1444307/000149315219006033/ownership.xml","form_type":"4"}}]}